Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)
| 1.75 Delayed Data As of 3:59pm ET |  +0.07 / +4.17%Today’s Change | 1.56 Today|||52-Week Range 6.33 | -55.58% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 130.0M | 83.3M | 90.3M | 63.2M | |
| Cost of Goods Sold | -- | -- | 399.0K | 691.0K | ||
| Depreciation And Amortization | 727.0K | 2.1M | 3.4M | 3.7M | ||
| Operating Expenses | Gross Income | -- | -- | 86.5M | 58.8M | |
| General Expenses | 118.3M | 219.1M | 221.1M | 162.1M | ||
| Research And Development | 95.2M | 178.2M | 156.8M | 100.2M | ||
| Total Operating Expenses | 119.0M | 221.2M | 224.9M | 166.5M | ||
| Non-Operating Expenses | Operating Income | 11.0M | -137.9M | -134.6M | -103.3M | |
| Extraordinary Credit | 0.00 | 703.0K | 0.00 | 0.00 | ||
| Extraordinary Charge | -9.5M | 0.00 | -2.1M | 0.00 | ||
| Interest Expense On Debt | 6.7M | 6.6M | 7.0M | 20.8M | ||
| Other Expenses | 572.0K | 2.3M | 0.00 | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -4.7M | -141.4M | -141.7M | -120.5M | |
| Income Taxes | 0.00 | 0.00 | -12.7M | 0.00 | ||
| Net Income | -4.7M | -141.4M | -129.1M | -120.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 103.6M | 103.9M | 105.2M | 105.8M | |
| Shares To Calculate EPS Diluted | 103.6M | 103.9M | 105.2M | 105.8M | ||
| Earnings Per Share | EPS | -$0.05 | -$1.36 | -$1.23 | -$1.14 | |
| EPS Diluted | -$0.05 | -$1.36 | -$1.23 | -$1.14 | ||
